Skip to main content
OpenTrials
Completed

NCT Number: NCT00637130

Safety and Intraocular Pressure (IOP) Lowering Efficacy of Low Dose Travoprost

The purpose of this study is to compare the safety and IOP-lowering efficacy of various low dose travoprost formulations in patients with open-angle glaucoma or ocular hypertension.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Open-angle Glaucoma Eye Diseases Glaucoma Glaucoma, Open-Angle Ocular Hypertension

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 2

Primary location

Contact Alcon Call Center at 1-888-451-3937

Fort Worth, Texas, 76134, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients 18 years of age or older, either sex or race with open-angle glaucoma or confirmed ocular hypertension
  • Other protocol-defined inclusion criteria may apply

Exclusion criteria

  • Age related
  • Other protocol-defined exclusion criteria may apply

Treatment and study plan

Travoprost ophthalmic solution, 0.0008%

Drug

Travoprost ophthalmic solution, 0.001%

Drug

Travoprost ophthalmic solution, 0.0012%

Drug

TRAVATAN

Drug

Vehicle

Other

Primary outcomes

  1. Mean Intraocular Pressure

    Time frame: Up to 2 weeks

Sponsors and collaborators

Lead sponsor

Alcon Research

Industry

Registry information

Official study title

Safety and IOP Lowering Efficacy of Low Dose Travoprost Ophthalmic Solutions Dosed BID Compared to TRAVATAN® in Patients With Open-Angle Glaucoma or Ocular Hypertension

Important dates

Study start
2007
Primary completion
2008
First posted
Mar 17, 2008
Registry last updated
Dec 6, 2012

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.